Navigation Links
Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
Date:5/1/2012

SWIFTWATER, Pa., May 1, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today new Phase III data for its investigational quadrivalent influenza vaccine (QIV) in children 6 months through 8 years of age. This pediatric study evaluated the safety and immunogenicity of QIV compared to currently licensed Fluzone® (Influenza Virus Vaccine). Results of the study were presented today at the Annual Meeting of the Pediatric Academic Societies in Boston.

The data from this pediatric study of QIV support the results of prior studies in adults. The non-inferiority comparisons demonstrate that the addition of a fourth influenza strain (a second B strain) to the investigational vaccine does not adversely affect the safety and immunogenicity profiles of QIV compared to those of licensed Fluzone vaccine. 

"Fluzone vaccine is the only influenza vaccine licensed and available in the U.S. for use in children as young as 6 months of age along with formulations of Fluzone vaccine available for the full spectrum of the population through the oldest adults," said David Greenberg, M.D., Senior Director, U.S. Scientific and Medical Affairs, Sanofi Pasteur. "We believe that a quadrivalent Fluzone vaccine could provide an important public health benefit for people of all ages by providing coverage against an extra B virus strain of influenza. Influenza B is responsible for a substantial burden of disease and influenza-associated complications and hospitalizations in children."

Currently, seasonal influenza vaccines contain the three influenza virus strains anticipated to circulate in a given year based on global surveillance of influenza virus activity during the prior year. The annual trivalent inactivated influenza vaccine (TIV) formulation includes two A strains and one B strain. However, f
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
2. NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign
3. Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program
4. UCSF, Sanofi Collaborate to Find New Diabetes Cures
5. Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-OneĀ® Competitor Product
6. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
7. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
8. Sanofi Tops Pfizer as Number One for Global Pharma Sales
9. Sanofi Pasteur Presents New Data Confirming FluzoneĀ® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population
10. Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine
11. Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... NEWTOWN, Pennsylvania , 21 de noviembre de ... servicios de ensayos clínicos externalizados y tecnologías eClinical, ... su aproximación de ,seguimiento inteligente, para el seguimiento ... El seguimiento inteligente amplía el concepto del seguimiento ... simple reducción de las visitas de seguimiento o ...
(Date:11/22/2014)... Research and Markets  has announced the addition ... 2014-2017" report to their offering. ... protein drug market has been expanding rapidly owing to ... like. During 2005-2013, sales of recombinant protein drugs available ... 19.1%, and it is projected that ...
(Date:11/21/2014)... , Nov. 21, 2014  Tandem Diabetes Care ... a medical device company and manufacturer of the ... partnership with Tidepool, a non-profit dedicated to improving ... software platform that increases diabetes data accessibility. This ... which is currently under development, to download and ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... Who Take DHA Have Healthier Pregnancies, Fewer Premature Births, ... nutritional,experts from a European Union (EU) committee now recommend ... basis with a large amount,of DHA, an essential omega-3 ... growing array of health benefits, nutritional,supplementation of DHA is ...
... Agent Administered in First-In-Human Study to Cancer Patients, ... Pharmaceuticals, Inc.,today announced that its first-in-humans Phase 1 ... is designed to evaluate the safety,pharmacokinetic and pharmacodynamic ... tumors. Study sites include TGen Clinical Research at,Scottsdale ...
Cached Medicine Technology:European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day 2Prolexys Pharmaceuticals Initiates Phase 1 Study 2
(Date:11/22/2014)... 22, 2014 A new technology ... today which safely detects and identifies hazards inside ... waves. Developed by RHT SpectraSafe, the technology avoids ... applications in other areas including medical, recycling, military, ... Using high frequency radio waves that pass harmlessly ...
(Date:11/22/2014)... Columbus, OH (PRWEB) November 22, 2014 ... trials for AndroGel side-effects lawsuits have been scheduled ... District Court, Northern District of Illinois. U.S. District Judge ... litigation, issued a Case Management Order (CMO) on November ... as deadlines for attorneys to submit documents and other ...
(Date:11/22/2014)... Many young people consider hookahs a hip and safer ... from the water pipes contain the toxin benzene. ... leukemia in prior research, according to a scientific team ... Biomarkers & Prevention . "In contrast to what ... alternative to smoking other forms of tobacco," study author ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- The widely used ... death and hospitalization among patients who have the heart ... failure, a new study finds. Atrial fibrillation is ... linked to a rise in risk for stroke among ... a century to help treat irregular heartbeat, the authors ...
(Date:11/21/2014)... Porcelain veneer dentist, Dr. ... in preparation for the coming holiday season. Veneers, ultra-thin ... look completely natural, and can be used to permanently ... valued for their ability to strengthen teeth. Veneers are ... on one or several teeth to rejuvenate appearance. Check ...
Breaking Medicine News(10 mins):Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2
... By Maureen Salamon HealthDay Reporter , ... women -- who presumably have more opportunities for tanning ... the lethal skin cancer melanoma as their poorest counterparts, ... relationship between melanoma incidence, ultraviolet (UV) light exposure and ...
... has discovered that a protein provides protection against the effects ... the study, funded by the Medical Research Council, could lead ... of people developing pancreatic cancer. The protein, calmodulin, is ... cells, the building blocks of the body. This study reveals ...
... government,s planned NHS and welfare reforms, and their use of ... from the end of the nineteenth century, according to studies ... recently been published in the Lancet . Dr ... from history, is his second in the Lancet within a ...
... given the choice between eating a hot dog or enjoying ... hot dogs, as well as pepperoni and deli meats, are ... research. But it,s a not-so-happy ending for bacon and rotisserie ... levels of cancerous material. J. Scott Smith, professor of ...
... Phoca vitulina ), which live in estuaries or along coastlines ... the result of a European study, involving Spanish participation, which ... Europe, even in the Mediterranean. "Although there are no ... biomonitors of global pollution", Octavio Prez Luzardo, one of the ...
... Reporter , MONDAY, March 21 (HealthDay News) -- New research ... kids: a certain type of ear infection. The new ... to alterations in children,s taste buds that change their sensitivity ... eat more of these foods and push them towards obesity, ...
Cached Medicine News:Health News:Richer White Women More Prone to Melanoma, Study Finds 2Health News:Richer White Women More Prone to Melanoma, Study Finds 3Health News:Protein could be used to treat alcohol effects on pancreas 2Health News:Report indicates that 'new' welfare reforms hark back to Victorians 2Health News:Good news for meat lovers: Most ready-to-eat meat products contain very few cancerous compounds 2Health News:European coastal pollution is harmful to seals 2Health News:Could a Type of Ear Infection Help Make Kids Obese? 2Health News:Could a Type of Ear Infection Help Make Kids Obese? 3
6mm HA Pins....
... The Ray TFC Unite Device is the anterior ... Ray TFC Unite device features the same 70% ... offered by fenestrations is paramount in the formation ... Ray TFC Unite system promotes load sharing between ...
... is the only approved radiolucent stand-alone implant ... with the proven reliability of the BAK ... System is constructed of radiolucent, carbon-fiber reinforced ... radiologic visualization, providing a new level of ...
... The VERSANT HIV-1 RNA Assay (bDNA) delivers ... confident that you're providing physicians with viral load ... the low end and at other critical decision ... assays. If you need more reasons to choose ...
Medicine Products: